Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA panel recommends approval of Novo Nordisk diabetes drug
A U.
Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
SEOUL (Reuters) - South Korean biosimilars maker Samsung Bioepis Co Ltd said on Tuesday it has applied to the U.
AstraZeneca highlights continued progress of oncology pipeline at ASCO 2016
AstraZeneca and its global biologics research and development arm, MedImmune, will provide an update on their extensive oncology pipeline at the annual meeting of the American Society of Clinical Onco...
FDA Approves Tecentriq (atezolizumab) for Urothelial Carcinoma
May 18, 2016 -- The U.
Deals this week: Trianni, ANI Pharma, Merus Labs
Trianni and Evotec AG have entered a co-development agreement to develop Evotec's existing drug discovery platforms, as well as new projects.
Osaka University concludes a comprehensive collaboration agreement with Chugai Pharmaceutical Co., Ltd.
Osaka University and Chugai Pharmaceutical Co.
Oramed Announces Positive Top-Line Results from Phase IIb Oral Insulin Study
JERUSALEM, May 18, 2016 /PRNewswire/ — Oramed Pharmaceuticals Inc.
Bayer makes takeover offer for agriculture giant Monsanto
German drug and chemicals-maker Bayer has made a takeover bid for agricultural giant Monsanto in a deal that could create the world's biggest supplier of seeds and pesticides.
Atezolizumab (Tecentriq) Wins FDA Nod for Bladder Cancer
The FDA has given the green light to atezolizumab (Tecentriq, Genentech) for the treatment of patients with urothelial carcinoma, the most common type of bladder cancer.
Alvotech Announces Acquisition of Baliopharm
REYKJAVIK, Iceland (BUSINESS WIRE) -- Alvotech, a powerful player in the field of biopharmaceuticals, today announced that it has entered into a definitive agreement to acquire Baliopharm GmbH...
Aduro Biotech Announces Phase 2b ECLIPSE Trial Misses Primary Endpoint in Heavily Pretreated Metastatic Pancreatic Cancer
BERKELEY, Calif.
Senate approves $1.1bn for Zika fight but House alternative bill provides far less
The US Senate on Tuesday took a step toward funding the Obama administration’s efforts to combat the Zika virus, but paved the way for a showdown with the House of Representatives, where Republicans...
622
623
624
625
626
627
628
629
630
